School of Medicine
Showing 101-150 of 212 Results
-
Stefan Thottunkal
Masters Student in Community Health and Prevention Research, admitted Winter 2025
SU Student Employee, Med/Quantitative Sciences UnitBioMasters Student in Community Health and Prevention Research, admitted Winter 2025
Stefan Thottunkal is an Australian medical student, early career researcher and civil servant. His research interests include chronic disease, Native health, and pharmacogenomics. He is particularly interested in pioneering deployment of innovative technologies in clinical settings, utilizing approaches grounded in implementation science. Stefan received an IIE QUAD Fellowship in 2024 to study a Masters of Community Health and Prevention Research at Stanford.
His current work focuses on precision medicine, advancing implementation of pharmacogenomic testing into clinical practice through leveraging machine learning and large language models to enhance clinical decision-making. He is actively seeking collaboration with students and faculty on this transformative project. Particularly those with a background in knowledge-grounded natural language processing and retrieval augmented generation
Stefan has worked on high impact initiatives conducted in collaboration with the WHO Global Outbreak and Response Network, Royal Australian College of General Practitioners and National Aboriginal Community Controlled Health Organization. He is passionate about bridging the gap between research, policy, and practice to drive meaningful change.
As a Research Officer at The National Centre for Aboriginal and Torres Strait Islander Well-being Research, Stefan worked on an evidence mapping review exploring implementation of health checks in the prevention and early detection of chronic diseases among Aboriginal and Torres Strait Islander people in Australian primary health care contexts. -
George F Tidmarsh
Adjunct Professor, Pediatrics - Neonatology
BioDr. Tidmarsh received M.D. and Ph.D. from Stanford University, where he also completed fellowship training in Pediatric Oncology and Neonatology and is currently Adjunct Faculty of Pediatrics and Neonatology. He served as clinical faculty at Stanford for a number of years after fellowship prior to devoting his full time to clinical research and development in order to bring new treatments through the FDA approval process. Dr. Tidmarsh was President, Chief Executive Officer, Secretary and a Director of La Jolla Pharmaceutical Company from January 2012 until November 2019. While at La Jolla, Dr. Tidmarsh helped discover the use of angiotensin II for the treatment of shock and led all aspects of the development including approval by the US FDA and the EMA for the treatment of patients suffering from distributive shock. He also led the development of artesunate for the treatment of severe malaria, now FDA approved. Dr. Tidmarsh has over 30 years of experience in biotechnology, including the successful clinical development of 6 FDA-approved drugs. He previously served as the Founder and Chief Executive Officer of Horizon Pharma, Inc., a company he founded in 2005. While at Horizon, he led all aspects of development of Duexis, which was approved by the FDA for the treatment of rheumatoid arthritis. In 2022, Horizon was sold to Amgen for $28B. He also founded Threshold Pharmaceuticals, Inc. and held senior positions at Coulter Pharmaceutical, Inc. (acquired by GlaxoSmithKline) and SEQUUS Pharmaceuticals, Inc. (acquired by Johnson & Johnson). While at Coulter and SEQUUS, Dr. Tidmarsh led the clinical development of BEXXAR and Doxil, respectively, two FDA-approved anti-cancer agents.
At Stanford, Dr. Tidmarsh is devoted to teaching clinical research and development to residents, fellows and junior faculty. He founded and taught the Masters in Translational Research and Applied Medicine, one of the only translational medicine programs at Stanford. In addition, he is working to help improve the quality of medical care through various efforts which include serving on the board of Lucile Packard Foundation for Children's Health, as co-Director of the Drug Device Development Program he started in 2017 and as a Senior Advisor for the Center for Pediatric and Perinatal Education (CAPE). He focuses most of his efforts currently on improving scientific data integrity in published literature. -
Molly Timmerman
Clinical Assistant Professor (Affiliated), Orthopaedic Surgery
BioDr. Molly Timmerman is board-certified in Physical Medicine and Rehabilitation. She is Affiliated Clinical Assistant Professor of Physical Medicine and Rehabilitation/Orthopedic Surgery. She practices at Veterans Health Administration in Palo Alto, where she is Medical Director of Regional Amputation Center and the Polytrauma Network Site. She specializes in traumatic brain injury, post-traumatic headache management, and amputation medicine.
-
Alexander Tolas
Clinical Research Coordinator, Medicine - Med/Cardiovascular Medicine
BioI’m passionate about the many intersections between health, technology, and behavior. Specifically with how wearable devices and mobile technologies can be leveraged to measure and promote better health outcomes across all populations. After earning my BS in Kinesiology, I have formed a strong analytical background in wearable technology and health through my involvement in numerous clinical health studies and research projects. To supplement my interest, I have had multiple academic pieces accepted by Medicine & Science in Sports & Exercise (MSSE) and The Journal for the Measurement of Physical Behaviour (ISMPB).
-
Sarina Tom
Associate Director for Education Operations, Pediatrics
Current Role at StanfordEducation Operations Manager
Office of Pediatric Education
Stanford Department of Pediatrics -
Caitlin Marie Toth
Assistant Clinical Research Coordinator, Emergency Medicine
Current Role at StanfordAssistant Clinical Research Coordinator
Stanford School of Medicine
Emergency Medicine Research -
Jo Townson
Director of Programs and Education, SoM - Physician Wellness
Current Role at StanfordDirector of Programs and Education
Stanford Medicine WellMD & WellPhD
